Levels of soluble triggering receptor expressed on myeloid cells 1 in infectious exacerbations of chronic obstructive pulmonary disease

Respiration

Volumn 83, Issue 2, 2012, Pages 133-139

  Rohde, Gernot ^a,d   Radsak, Markus P ^b,c   Borg, Irmgard ^d   Buhl, Roland ^b   Schultze Werninghaus, Gerhard ^d   Taube, Christian ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b 3rd Medical Department   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Biomarker; Chronic obstructive pulmonary disease; Exacerbation; Inflammation; Pathogen; Virus

Indexed keywords

TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BONE MARROW CELL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME ACTIVITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; INFLUENZA VIRUS A; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; NASAL LAVAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; SMOKING HABIT; SPUTUM CULTURE;

ACUTE DISEASE; ADULT; AGED; DNA, VIRAL; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, IMMUNOLOGIC; SMOKING; SPUTUM;

EID: 84856414837     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000328413     Document Type: Article

References (39)

1. Murphy TF: The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis 2006;19:225-230.
2. Gan WQ, Man SF, Senthilselvan A, Sin DD: Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-580.
3. van Eeden SF, Sin DD: Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 2008;75:224-238.
4. Bouchon A, Dietrich J, Colonna M: Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000;164:4991-4995.
5. Schenk M, Bouchon A, Birrer S, Colonna M, Mueller C: Macrophages expressing triggering receptor expressed on myeloid cells-1 are underrepresented in the human intestine. J Immunol 2005;174:517-524.
6. Haselmayer P, Daniel M, Tertilt C, Salih HR, Stassen M, Schild H, Radsak MP: Signaling pathways of the TREM-1-and TLR4-mediated neutrophil oxidative burst. J Innate Immun 2009;1:582-591.
7. Radsak MP, Salih HR, Rammensee HG, Schild H: Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol 2004;172:4956-4963.
8. Haselmayer P, Grosse-Hovest L, von Landenberg P, Schild H, Radsak MP: TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 2007;110:1029-1035.
9. Gingras MC, Lapillonne H, Margolin JF: TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development. Mol Immunol 2002;38:817-824.
10. Gibot S: Clinical review: role of triggering receptor expressed on myeloid cells-1 during sepsis. Crit Care 2005;9:485-489.
11. Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE: Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004;350:451-458.
12. Tejera A, Santolaria F, Diez ML, Aleman-Valls MR, Gonzalez-Reimers E, Martinez-Riera A, Milena-Abril A: Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine 2007;38:117-123.
13. Wong-Baeza I, Gonzalez-Roldan N, Ferat-Osorio E, Esquivel-Callejas N, Aduna-Vicente R, Arriaga-Pizano L, Astudillo-de la Vega H, Villasis-Keever MA, Torres-Gonzalez R, Estrada-Garcia I, Lopez-Macias C, Isibasi A: Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients. Clin Exp Immunol 2006;145:448-455.
14. Ferat-Osorio E, Wong-Baeza I, Esquivel-Callejas N, Figueroa-Figueroa S, Duarte-Rojo A, Guzman-Valdivia-Gomez G, Rodea-Rosas H, Torres-Gonzalez R, Sanchez-Fernandez P, Arriaga-Pizano L, Lopez-Macias C, Robles-Diaz G, Isibasi A: Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitis. Crit Care 2009;13:R69.
15. Collins CE, La DT, Yang HT, Massin F, Gibot S, Faure G, Stohl W: Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis. Ann Rheum Dis 2009;68:1768-1774.
16. Schenk M, Bouchon A, Seibold F, Mueller C: TREM-1 - expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. J Clin Invest 2007;117:3097-3106.
17. Park JJ, Cheon JH, Kim BY, Kim DH, Kim ES, Kim TI, Lee KR, Kim WH: Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease. Dig Dis Sci 2009;54:1525-1531.
18. Radsak MP, Taube C, Haselmayer P, Tenzer S, Salih HR, Wiewrodt R, Buhl R, Schild H: Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease. Clin Dev Immunol 2007;2007:52040.
19. Mallia P, Johnston SL: Mechanisms and experimental models of chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc 2005;2:361-366, discussion 71-72.
20. Sethi S: Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease. Semin Respir Crit Care Med 2005;26:192-203.
21. Larsen MV, Janner JH, Nielsen SD, Friis-Moller A, Ringbaek T, Lange P: Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital. Scand J Infect Dis 2009;41:26-32.
22. Rohde G, Wiethege A, Borg I, Kauth M, Bauer TT, Gillissen A, Bufe A, Schultze-Werninghaus G: Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalization - a casecontrol study. Thorax 2003;58:37-42.
23. Gencay M, Roth M, Christ-Crain M, Mueller B, Tamm M, Stolz D: Single and multiple viral infections in lower respiratory tract infection. Respiration 2010;80:560-567.
24. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA: Antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
25. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL: Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006;173:1114-1121.
26. Celli BR, Barnes PJ: Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007;29:1224-1238.
27. Sethi S, Maloney J, Grove L, Wrona C, Berenson CS: Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:991-998.
28. Hayashi S, Hogg JC: Adenovirus infections and lung disease. Curr Opin Pharmacol 2007;7:237-243.
29. Borg I, Rohde G, Loeseke S, Bittscheid J, Schultze-Werninghaus G, Stephan V, Bufe A: Evaluation of a quantitative real-time PCR for the detection of RSV in pulmonary diseases. Eur Respir J 2003;21:944-951.
30. Gibot S, Kolopp-Sarda MN, Bene MC, Cravoisy A, Levy B, Faure GC, Bollaert PE: Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004;141:9-15.
31. Gibot S: Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia and severe sepsis. Semin Respir Crit Care Med 2006;27:29-33.
32. Rohde G, Gevaert P, Holtappels G, Fransen L, Borg I, Wiethege A, Arinir U, Schultze-Wernighaus G, Bachert C: Soluble IL-5 receptor alpha is increased in acute exacerbation of COPD. Int Arch Allergy Immunol 2004;135:54-61.
33. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276.
34. Rohde G, Wiethege A, Borg I, Arinir U, Schürmann A, Löseke S, Kauth M, Bufe A, Schultze-Werninghaus G: Influenza A virus in exacerbation of chronic obstructive pulmonary disease. Eur Respir J 2001;18(suppl 33):152s.
35. Arinir U, Borg I, Rohde G, Keller P, Loesecke S, Schuermann A, Wiethege A, Bufe A, Schultze-Werninghaus G: Rhinovirus infection in chronic obstructive pulmonary disease. Eur Respir J 2002;20(suppl 38):591s.
36. Rohde G, Borg I, Wiethege A, Kauth M, Jerzinowski S, Duong Dinh TA, Bauer TT, Bufe A, Schultze-Wernighaus G: Inflammatory response in acute viral exacerbations of COPD. Infection 2008;36:427-433.
37. Phua J, Koay ES, Zhang D, Tai LK, Boo XL, Lim KC, Lim TK: Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections. Eur Respir J 2006;28:695-702.
38. Muller B, Gencay MM, Gibot S, Stolz D, Hunziker L, Tamm M, Christ-Crain M: Circulating levels of soluble triggering receptor expressed on myeloid cells (sTREM)-1 in community-acquired pneumonia. Crit Care Med 2007;35:990-991.
39. Qvarfordt I, Riise GC, Andersson BA, Larsson S: Lower airway bacterial colonization in asymptomatic smokers and smokers with chronic bronchitis and recurrent exacerbations. Respir Med 2000;94:881-887.